MedTrace Logo

4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation

NCT01764659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2020-03-27

Study results available
· View outcomes & findings →

Summary

The primary objective is to study the feasibility and efficacy of individually optimized CE 4D-CT for PDA in radiotherapy simulation.

Conditions

  • Pancreatic Adenocarcinoma

Interventions

OTHER

Contrast-enhanced 4D computed tomography

All enrolled patients each underwent three CT scans: a 4DCT immediately following a contrast-enhanced 3DCT and an individually optimized contrast-enhanced 4DCT.

Sponsors & Collaborators

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Wei Lu, Ph. D., DABR · UMMC MSGCC

  • Hao H Zhang, Ph. D. · UMMC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01764659 on ClinicalTrials.gov